World Health Organization

New global commitment to end TB

Over 120 national delegations that participated in the first Global Ministerial Conference on TB adopted the Moscow Declaration to End TB.

Read More →

Less than one week to go: First WHO Global Ministerial Conference on Ending TB

75 Ministers, 114 country delegations and over 1000 participants registered

Read More →

Compendium of WHO guidelines and associated standards

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis

Read More →

Personal stories from TB survivors: My journey fighting TB

Tuberculosis (TB) is the world's top infectious killer today. It is airborne and can affect any one of us. Over 5 000 women, men and children still die each day from TB. The social and economic impacts are devastating, including poverty, stigma and discrimination. This disease is curable and preventable, yet global actions and investments fall far short of those needed to end the global TB epidemic.

Read More →

Global TB Report 2017

WHO report signals urgent need for greater political commitment to end TB; TB remains leading infectious killer.

Read More →

WHO to review its interim guidance on the use of delamanid in the treatment of multidrug-resistant TB following the release of Phase III clinical trial results

The World Health Organization (WHO) has started preparations for a rapid review of its interim guidance on the use of delamanid in the treatment of patients with multidrug-resistant tuberculosis (MDR-TB). This follows the release of the phase III randomised control trial results by Otsuka Pharmaceutical at the 48th Union World Conference on Lung Health on 13 October.

Read More →

The world is running out of antibiotics, WHO report confirms

WHO report highlights TB as a top priority for research and development of new antibiotics.

Read More →

Align national TB strategies with commitment to end TB by 2030: WHO

Male, Maldives, 10 September 2017 - World Health Organization has called on countries in South-East Asia Region to build on recent momentum aimed at ending TB by 2030, commending their resolve to take action and urging all countries to review and align national plans with the Delhi Call to Action.

Read More →

WHO prequalifies key treatment for children with TB

01 September 2017 - WHO has just prequalified a two-pills-in-one paediatric medicine that is critical for the continuation phase of the six-month treatment required to cure tuberculosis (TB). The medicine – rifampicin 75mg + isoniazid 50mg – is a fixed dose combination (FDC) tablet manufactured by Macleods Pharmaceuticals Limited. WHO medicines prequalification activities are partly funded by the Bill & Melinda Gates Foundation and by Unitaid.

Read More →

WHO applauds the launch of Thailand's First National Tuberculosis Research Roadmap

Geneva, 30 August 2017 – Recognizing the need for innovative tools and strategies to bolster the country’s response to end TB, Thailand’s national TB research network (ThaiTurn) has just launched the country’s first national TB research roadmap. The roadmap includes research priorities targeted at addressing health systems challenges, as well as the prevention and treatment of multidrug-resistant TB (MDR-TB).

Read More →

Page 2 of 12 · Total posts: 10

←First 1 2 3 Last→